Tagged with R

VGX International Could you briefly introduce VGX International to our readers, and in particular explain its relation to US-based company VGX Pharmaceutical (VGXP)? The backbone of VGXP is the University of Pennsylvania in terms of the research grant and Dr. David Weiner as the scientific chief of the company and the brain…

Grunenthal Italy Grunenthal-Formenti relies on Formenti’s 60 years experience in Italy and is the result of the merger of both the German and Italian entities in 96. How would you describe the process of integrating and combining both cultures to lead an Italo-German company, building on the already existing Italian heritage and…

Novo Nordsik South Korea You have a very long track record working with Novo Nordisk in Asia. What is your perspective on the Diabetes explosion that has been taking place in this part of the world in recent years? First of all, the explosion is real. We know from data in both Hong Kong…

generics “The ball is in the hands of the government,” according to Giorgio Foresti, general manager of Ratiopharm. “Once aware of the opportunities created by generics, politicians will have to make hard decisions.” Until now, generics prescriptions were limited by strong links between innovators and doctors, and price alignment trends reducing…

Korea   Already an economic powerhouse thriving on export-driven industries such as electronics, automotive and ship-building, South Korea is now looking to boost its potential in the life sciences and to move towards an innovation-based economy. Though it may traditionally be known in the West as ‘The Land of the Morning…

Greece Greece’s contributions to health are world-renowned, whether physical through its Mediterranean diet and climate, or mental as the genesis of western philosophy and mathematics. Less well-known, however, are its modern-day activities in the pharmaceutical industry, where the blossoming market is distinctive for its diversity despite a small size of 11…

Brazil   With its huge market of 186 million people; its current position as the largest pharma market in Latin America, with strong growth projected; the influx of foreign and local investment into its pharma market; its reputation for conducting high-quality clinical research; and its incredible biological diversity, Brazil seems poised…

Russia   When the Russian Federation emerged from the former USSR in 1991 all the structures of the past social net that provided for the complete healthcare needs of citizens were just a memory of the past – nothing was left when the centralized distribution of medication of the former USSR…

Pharma Legal Handbook An intro to the legal situation for orphan drugs and rare diseases in Russia. Prepared in association with Lidings, a leading global law firm, this is an extract from The Pharma Legal Handbook: Russia, available to purchase here for GBP 99.     1. What is the definition of Rare Diseases…

Pharma Legal Handbook The ins and outs of traditional medicines and OTC products in Greek pharma. Prepared in association with Calavros Law Firm, a leading global law firm, this is an extract from The Pharma Legal Handbook: Greece, available to purchase here for USD 99.   1. What are the regulatory requirements for traditional, herbal, complementary,…